Total Payments
$17,574
2024 Payments
$3,065
Companies
26
Transactions
712
Medicare Patients
439
Medicare Billing
$53,780
Payment Breakdown by Category
Food & Beverage$17,574 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,574 | 712 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $3,221 | 118 | $0 (2024) |
| Alkermes, Inc. | $2,713 | 87 | $0 (2024) |
| ABBVIE INC. | $2,436 | 132 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $2,330 | 82 | $0 (2024) |
| Allergan, Inc. | $1,931 | 59 | $0 (2020) |
| ITI, Inc. | $762.49 | 25 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $709.93 | 30 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $708.14 | 28 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $641.30 | 50 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $423.71 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,065 | 110 | ABBVIE INC. ($685.00) |
| 2023 | $3,401 | 150 | ABBVIE INC. ($730.36) |
| 2022 | $2,720 | 116 | Alkermes, Inc. ($810.94) |
| 2021 | $2,172 | 89 | Alkermes, Inc. ($797.81) |
| 2020 | $1,231 | 61 | Allergan, Inc. ($410.66) |
| 2019 | $1,922 | 69 | Allergan Inc. ($836.73) |
| 2018 | $3,001 | 112 | Otsuka America Pharmaceutical, Inc. ($686.24) |
| 2017 | $62.81 | 5 | Sunovion Pharmaceuticals Inc. ($44.97) |
All Payment Transactions
712 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Neuroscience | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.57 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | Tris Pharma Inc | Onyda XR (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: ADHD | ||||||
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.51 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: ADHD | ||||||
| 12/05/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $74.89 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $4.30 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $122.03 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $57.59 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Neuroscience | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Neuropsychiatry | ||||||
| 10/31/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: Neuroscience | ||||||
| 10/31/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Neuropsychiatry | ||||||
| 10/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 187 | 431 | $52,170 | $24,182 |
| 2022 | 2 | 144 | 217 | $39,150 | $15,914 |
| 2021 | 2 | 52 | 100 | $14,938 | $6,832 |
| 2020 | 2 | 56 | 94 | $15,310 | $6,852 |
Total Patients
439
Total Services
842
Medicare Billing
$53,780
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 249 | $32,150 | $14,836 | 46.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 86 | 182 | $20,020 | $9,346 | 46.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 129 | $19,350 | $8,924 | 46.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 88 | $19,800 | $6,990 | 35.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 41 | 89 | $13,343 | $6,559 | 49.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 11 | $1,595 | $273.55 | 17.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 40 | 78 | $11,310 | $5,154 | 45.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 16 | 16 | $4,000 | $1,698 | 42.4% |
About Dr. Japhet Gaztambide, M.D
Dr. Japhet Gaztambide, M.D is a Psychiatry healthcare provider based in Aguadilla, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1215074331.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Japhet Gaztambide, M.D has received a total of $17,574 in payments from pharmaceutical and medical device companies, with $3,065 received in 2024. These payments were reported across 712 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($17,574).
As a Medicare-enrolled provider, Gaztambide has provided services to 439 Medicare beneficiaries, totaling 842 services with total Medicare billing of $53,780. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Aguadilla, PR
- Active Since 01/30/2007
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215074331
Products in Payments
- VRAYLAR (Drug) $4,356
- ABILIFY MAINTENA (Drug) $1,587
- REXULTI (Drug) $1,464
- INVEGA SUSTENNA (Drug) $1,383
- ARISTADA (Drug) $1,213
- LYBALVI (Drug) $1,200
- CAPLYTA (Drug) $958.71
- SPRAVATO (Drug) $834.51
- INGREZZA (Drug) $709.93
- LATUDA (Drug) $641.30
- Auvelity (Drug) $400.24
- Austedo XR (Drug) $340.21
- Aristada 441 mg (Drug) $271.01
- TRINTELLIX (Drug) $249.90
- UZEDY (Drug) $230.24
- ABILIFY ASIMTUFII (Drug) $209.91
- HETLIOZ (Drug) $176.47
- AUSTEDO (Drug) $137.69
- MYDAYIS (Drug) $134.36
- Trintellix (Drug) $133.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.